Medical biotechnology industry

This undated microscope image provided by the American Society for Reproductive Medicine in January 2018 shows a trophectoderm biopsy, in which cells from the outer layer of an embryo that develop into the placenta and amniotic membranes are removed and can be used for genetic testing. When a couple is known to be at risk for having a child with a specific genetic disorder, the woman undergoes a procedure to remove some of her eggs. After fertilization, some cells can be plucked from the embryos and examined to identify those without carry the disease-causing abnormality. (ASRM via AP)Wedn
April 18, 2018 - 1:11 am
NEW YORK (AP) — So you want to have a baby. Would you like a dark-haired girl with a high risk of someday getting colon cancer, but a good chance of above-average music ability? Or would you prefer a girl with a good prospect for high SAT scores and a good shot at being athletic, but who also is...
Read More
February 14, 2018 - 2:58 pm
CHICAGO (AP) — The first blood test to help doctors diagnose traumatic brain injuries has won U.S. government approval. The move means Banyan Biomarkers can commercialize its test, giving the company an early lead in the biotech industry's race to find a way to diagnose concussions. The test doesn'...
Read More

Pages